VF
ALBO

Virtu Financial’s Albireo Pharma Inc ALBO Stock Holding History

Virtu Financial’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-14,969
Closed -$527K – 2180
2021
Q2 		$527K Buy
+14,969
New +$487K 0.05% 451
2020
Q3 		– Sell
-8,256
Closed -$219K – 1686
2020
Q2 		$219K Buy
+8,256
New +$195K 0.03% 680

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Virtu Financial's ALBO Position: Q3 2021 in Review

Virtu Financial sold out of Albireo Pharma Inc (ALBO) in Q3 2021, closing a stake of 14,969 shares — an estimated $527K sold.

Virtu Financial first reported a position in ALBO in Q2 2020 and held it in 2 quarters. The position peaked at $527K in Q2 2021. 94 funds tracked by Wall St. Rank hold ALBO as of Q3 2021.

  • Virtu Financial reported no remaining Albireo Pharma Inc position as of Q3 2021 after selling out during the quarter.
  • Virtu Financial sold 14,969 Albireo Pharma Inc shares in Q3 2021, an estimated $527K.
  • Virtu Financial first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 2 quarters.
  • Virtu Financial's Albireo Pharma Inc position peaked at $527K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2021.

Based on Virtu Financial's 13F filing for Q3 2021, filed 12 Nov 2021.